Literature DB >> 17540903

Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death.

Matthew B Reeves1, Andrew A Davies, Brian P McSharry, Gavin W Wilkinson, John H Sinclair.   

Abstract

Human cytomegalovirus infection perturbs multiple cellular processes that could promote the release of proapoptotic stimuli. Consequently, it encodes mechanisms to prevent cell death during infection. Using rotenone, a potent inhibitor of the mitochondrial enzyme complex I (reduced nicotinamide adenine dinucleotide-ubiquinone oxido-reductase), we found that human cytomegalovirus infection protected cells from rotenone-induced apoptosis, a protection mediated by a 2.7-kilobase virally encoded RNA (beta2.7). During infection, beta2.7 RNA interacted with complex I and prevented the relocalization of the essential subunit genes associated with retinoid/interferon-induced mortality-19, in response to apoptotic stimuli. This interaction, which is important for stabilizing the mitochondrial membrane potential, resulted in continued adenosine triphosphate production, which is critical for the successful completion of the virus' life cycle. Complex I targeting by a viral RNA represents a refined strategy to modulate the metabolic viability of the infected host cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540903     DOI: 10.1126/science.1142984

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  135 in total

1.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 2.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

3.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 4.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 5.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

6.  GRIM-19 is essential for maintenance of mitochondrial membrane potential.

Authors:  Hao Lu; Xinmin Cao
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

Review 7.  Genomics and the immune system.

Authors:  Matthew E Pipkin; Silvia Monticelli
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

Review 8.  Eukaryotic complex I: functional diversity and experimental systems to unravel the assembly process.

Authors:  Claire Remacle; M Rosario Barbieri; Pierre Cardol; Patrice P Hamel
Journal:  Mol Genet Genomics       Date:  2008-06-18       Impact factor: 3.291

9.  Viral mitochondria-localized inhibitor of apoptosis (UL37 exon 1 protein) does not protect human neural precursor cells from human cytomegalovirus-induced cell death.

Authors:  Richard L Hildreth; Matthew D Bullough; Aiping Zhang; Hui-Ling Chen; Philip H Schwartz; David M Panchision; Anamaris M Colberg-Poley
Journal:  J Gen Virol       Date:  2012-08-08       Impact factor: 3.891

10.  Regulation of the subcellular distribution of key cellular RNA-processing factors during permissive human cytomegalovirus infection.

Authors:  Charla E Gaddy; Daniel S Wong; Ariel Markowitz-Shulman; Anamaris M Colberg-Poley
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.